Samsung Releases Lower-Cost Alternative to J&J's Drug Remicade

South Korea’s Samsung conglomerate, best known for its smartphones and televisions, will make available on Monday in the U.S. its lower-price copy of Johnson & Johnson’s blockbuster rheumatoid-arthritis drug Remicade

from WSJ.com: US Business http://ift.tt/2vBxh9F
via IFTTT